All‑trans retinoic acid enhances the effect of 5‑aza‑2'‑deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell line

Xiang,Lili; Dong,Weimin; Wang,Rong; Wei,Jiang; Qiu,Guoqiang; Cen,Jiannong; Chen,Zixing; Zheng,Xiao; Hu,Shaoyan; Xie,Xiaobao; Cao,Xiangshan; Gu,Weiying

doi:10.3892/ol.2014.2133

July-2014 Volume 8 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2014 Volume 8 Issue 1

Full Size Image

Article

All‑trans retinoic acid enhances the effect of 5‑aza‑2'‑deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell line

Authors:
- Lili Xiang
- Weimin Dong
- Rong Wang
- Jiang Wei
- Guoqiang Qiu
- Jiannong Cen
- Zixing Chen
- Xiao Zheng
- Shaoyan Hu
- Xiaobao Xie
- Xiangshan Cao
- Weiying Gu
View Affiliations / Copyright

Affiliations: Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, P.R. China, Laboratory of China and United States Cooperation, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, P.R. China, Comprehensive Laboratory, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, P.R. China, Hematology Laboratory, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, P.R. China, Jiangsu Institute of Hematology, The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, P.R. China, Laboratory of Tumor, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, P.R. China, Department of Hematology and Oncology, Children's Hospital of Suzhou University, Suzhou, Jiangsu, P.R. China
Pages: 117-122
|
Published online on: May 12, 2014

https://doi.org/10.3892/ol.2014.2133
Expand metrics +

Abstract

The aim of the current study was to investigate the antineoplastic activities of 5‑aza‑2'‑deoxycytidine (also known as decitabine; DAC) and all‑trans retinoic acid (ATRA), administered alone or in combination, in K562 cells in vitro, as well as the effects on the expression of the tumor suppressor genes, p16INK4a (p16) and retinoic acid receptor β (RAR‑β). Cell growth inhibition, differentiation and apoptosis in K562 cells treated with DAC and/or ATRA were detected. The methylation of the p16 and RAR‑β genes in the K562 cells was detected using the methylation‑specific polymerase chain reaction (PCR) method. Quantitative PCR was used for the detection of the mRNA expression of the p16 and RAR‑β genes, and western blot analysis was used to detect protein expression. DAC and ATRA, alone or in combination, had no effect on the growth inhibition, differentiation and apoptosis of the K562 cells. DAC alone induced the demethylation of the p16 gene, and combination of DAC and ATRA demonstrated more evident demethylation of the p16 gene, however, ATRA alone had no effect on methylation. The RAR‑β promoter region was not methylated in the K562 cells. DAC in combination with ATRA appeared to produce a greater activation of the RAR‑β gene, which led to the upregulation of the RAR‑β expression level. ATRA enhanced the effect of DAC on p16 demethylation, and the combination of the two drugs was found to activate RAR‑β expression, which indicated that DAC used in combination with ATRA has clinical potential in the treatment of human erythroleukemia.

View Figures

View References

1	Issa J, Vertino PM, Boehm CD, et al: Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA. 93:11757–11762. 1996.
2	Melki JR and Clark SJ: DNA methylation changes in leukaemia. Semin Cancer Biol. 12:347–357. 2002.
3	Takai D, Gonzales FA, Tsai YC, et al: Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet. 10:2619–2626. 2001.
4	Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al; International Vidaza High-Risk MDS Survival Study Group. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 10:223–232. 2009.
5	Steensma DP, Baer MR, Slack JL, et al: Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial. J Clin Oncol. 27:3842–3848. 2009.
6	Voso MT, Santini V, Finelli C, et al: Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res. 15:5002–5007. 2009.
7	Merlo A, Herman JG, Mao L, et al: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1:686–692. 1995.
8	Herman JG, Jen J, Merlo A and Baylin SB: Hypermeth- ylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56:722–727. 1996.
9	Côté S, Sinnett D and Momparler RL: Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs. 9:743–750. 1998.
10	Breitman TR, Selonick SE and Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 77:2936–2940. 1980.
11	Honma Y, Takenaga K, Kasukabe T and Hozumi M: Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun. 95:507–512. 1980.
12	Momparler RL, Bouchard J and Samson J: Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2′-deoxycytidine. Leuk Res. 9:1361–1366. 1985.
13	Liu Z, Zhang L, Ding F, et al: 5-Aza-2′-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Cancer Lett. 230:271–283. 2005.
14	Miasaki FY, Vivaldi A, Ciampi R, et al: Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2′-deoxycytidine treatment. J Endocrinol Invest. 31:724–730. 2008.
15	Aoyama S, Nakano H, Danbara M, et al: The differentiating and apoptotic effects of 2-aza-5′-deoxycytidine are dependent on the PU.1 expression level in PU1-transgenic K562 cells. Biochem Biophys Res Commun. 420:775–781. 2012.
16	Herman JG, Civin CI, Issa JP, et al: Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57:837–841. 1997.
17	Uenogawa K, Hatta Y, Arima N, et al: Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma. Int J Mol Med. 28:835–839. 2011.